These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6194134)

  • 1. Behavioral effects of substance P in rats.
    Barbeau A; Rondeau DB; Jolicoeur FB
    Int J Neurol; 1980; 14(2-4):239-52. PubMed ID: 6194134
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral alterations induced by substance P, bombesin, and related peptides in mice.
    Meisenberg G; Simmons WH
    Peptides; 1986; 7(4):557-61. PubMed ID: 2429288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grooming behavior induced by substance P.
    Van Wimersma Greidanus TB; Maigret C
    Eur J Pharmacol; 1988 Sep; 154(2):217-20. PubMed ID: 2465909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response effects of beta-phenylethylamine on stereotyped behavior in pargyline-pretreated rats.
    Moja EA; Stoff DM; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1976 Dec; 11(6):731-42. PubMed ID: 1033771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
    Berridge KC; Aldridge JW
    Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of behavioral and neurochemical effects of cocaine by haloperidol.
    Bhattacharyya AK; Aulakh CS; Pradhan S; Ghosh P; Pradhan SN
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):71-80. PubMed ID: 39530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some considerations regarding the characterization and interpretation of neuropeptide-induced behavioral changes.
    Segal DS
    Neurosci Res Program Bull; 1978 Dec; 16(4):510-20. PubMed ID: 35764
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioural response to bilateral injections of substance P into the substantia nigra of the rat.
    Kelley AE; Iversen SD
    Brain Res; 1978 Dec; 158(2):474-8. PubMed ID: 709379
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of substance P on the behavioral changes induced by haloperidol in rats.
    Jolicoeur FB; Rondeau DB; Belanger F; Fouriezos G; Barbeau A
    Peptides; 1980; 1(1):103-7. PubMed ID: 6165976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P and behavior: opposite effects of N-terminal and C-terminal fragments.
    Hall ME; Stewart JM
    Peptides; 1983; 4(5):763-8. PubMed ID: 6197702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral effects of deprenyl in aged rats.
    Drago F; Continella G; Spadaro F; Cavaliere S; Scapagnini U
    Funct Neurol; 1986; 1(2):165-74. PubMed ID: 3111946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin and carbetocin effects on spontaneous behavior of male rats: modulation by oxytocin receptor antagonists.
    Klenerova V; Krejci I; Sida P; Hlinak Z; Hynie S
    Neuro Endocrinol Lett; 2009; 30(3):335-42. PubMed ID: 19855356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and immunological effects of substance P in female and male mice.
    Teixeira RM; Duarte FS; De Lima TC
    Pharmacol Biochem Behav; 2004 Sep; 79(1):1-9. PubMed ID: 15388277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of substance P on behavioral indicators in "open field" and "forced swimming" tests in rats of different behavioral types].
    Sarlospva IIu; Kulikov MA; Kolomeĭtseva IA
    Biull Eksp Biol Med; 1996 Mar; 121(3):244-7. PubMed ID: 8688517
    [No Abstract]   [Full Text] [Related]  

  • 19. Different effects of adenosine A1 agonist ribavirin on amphetamine-induced total locomotor and stereotypic activities in rats.
    Janać B; Pesić V; Peković S; Rakić L; Stojiljković M
    Ann N Y Acad Sci; 2005 Jun; 1048():396-9. PubMed ID: 16154961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The neurotropic effect of myelopide on rat motor activity--stereotypical movement, locomotion, and grooming].
    Lepekhina LM; Bibkova LA
    Biull Eksp Biol Med; 1994 Oct; 118(10):414-6. PubMed ID: 7865823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.